NCT06051448CompletedPhase 1/2
Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).
Harnessing Resilience in Adults With Primary Mitochondrial Disease: A Pilot Study Investigating the Feasibility of the Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Interventions
Source: ClinicalTrials.gov · Last updated 29 Nov 2024
Brief summary (registry, in English)
The goal of this study is to find the best way to help people with primary mitochondrial disease deal with the stress of their condition, and to help these people be better able to "bounce back," or be resilient. In order to do this, the investigators are going to test two interventions (an intervention means that it aims to change something): Promoting Resilience in Stress Management (PRISM) and clinical-focused narrative (CFN) intervention.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 12 Sept 2023
- Start date
- 22 Sept 2023
- Primary completion date
- 28 Feb 2024
- Lead sponsor
- Children's Hospital of Philadelphia
- NCT number
- NCT06051448
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 16
- From 22 Sept 2023 to the primary completion date, 28 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Suspected but no molecular diagnosis primary mitochondrial disease
Who the study is looking for
- Males or females at least 18 years old
- Capable of giving consent, or there is a legally authorized representative capable of giving consent on the subject behalf and if appropriate, assent.
- Able to speak and read English
- Able to participate in Web- and App-based interventions
- Confirmed molecular diagnosis of primary mitochondrial disease
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital of Philadelphia Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.